Shares of Aptose Biosciences Inc. (NASDAQ:APTO – Get Free Report) (TSE:APS) have earned an average rating of “Buy” from the five research firms that are currently covering the stock, MarketBeat.com reports. Five equities research analysts have rated the stock with a buy recommendation. The average 1-year price objective among brokerages that have issued a report […]